Garry Cuneo
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- Enzyme function and inhibition
- DNA and Nucleic Acid Chemistry
Papers in
-
- Enzyme function and inhibition 3
-
- Prostate Cancer Treatment and Research 1
- Co-authors
- Donald E. Ingber (2 shared papers)Maartje M. C. Bastings (1 shared paper)Chenxiang Lin (1 shared paper)Ju Hee Ryu (1 shared paper)Frances M. Anastassacos (1 shared paper)Nandhini Ponnuswamy (1 shared paper)William M. Shih (1 shared paper)Franziska Leifer (1 shared paper)
- Journals
- Nano Letters (1 paper)Molecular Imaging and Biology (1 paper)PLoS ONE (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Biomaterials (1 paper)
- Partner nations
- United StatesItalySouth Korea
In The Last Decade
Garry Cuneo
8 papers receiving 474 citations
Peers
Comparison fields: 5 of 60
- Biomaterials 68
- Molecular Biology 306
- Biomedical Engineering 164
- Pharmaceutical Science 18
- Cancer Research 39
Countries citing papers authored by Garry Cuneo
This map shows the geographic impact of Garry Cuneo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Cuneo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Cuneo more than expected).
Fields of papers citing papers by Garry Cuneo
This network shows the impact of papers produced by Garry Cuneo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Cuneo. The network helps show where Garry Cuneo may publish in the future.
Co-authors
The 25 scholars most cited alongside Garry Cuneo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 209 | |
| 2 | 2009 | 70 | |
| 3 | 2017 | 62 | |
| 4 | 2012 | 56 | |
| 5 | 2011 | 43 | |
| 6 | 2011 | 31 | |
| 7 | 2013 | 6 | |
| 8 | 2012 | 1 |
About Garry Cuneo
Garry Cuneo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Biomedical Engineering and Organic Chemistry, having authored 8 papers that have together received 478 indexed citations. Recurring topics across this work include Enzyme function and inhibition (3 papers), Nanoplatforms for cancer theranostics (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Ultrasound and Hyperthermia Applications (1 paper), Synthesis and Catalytic Reactions (1 paper), Prostate Cancer Treatment and Research (1 paper), Optical Imaging and Spectroscopy Techniques (1 paper) and Gold and Silver Nanoparticles Synthesis and Applications (1 paper). The work is most often cited by research in Biomaterials (68 citations), Molecular Biology (306 citations), Biomedical Engineering (164 citations), Pharmaceutical Science (18 citations) and Cancer Research (39 citations). Garry Cuneo has collaborated with scholars based in United States, Italy and South Korea. Frequent co-authors include Donald E. Ingber, Maartje M. C. Bastings, Chenxiang Lin, Ju Hee Ryu, Frances M. Anastassacos, Nandhini Ponnuswamy, William M. Shih, Franziska Leifer, Jeffrey D. Peterson and Milind Rajopadhye. Their work appears in journals such as Nano Letters, Molecular Imaging and Biology, PLoS ONE, Bioorganic & Medicinal Chemistry Letters and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.